Arndt Vogel: How to best manage Immune-Related Adverse Events?
Arndt Vogel, Managing Senior Consultant and Professor in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School, shared on X/Twitter:
“How to best manage Immune-Related Adverse Events? Impact of immunosuppressive agents on the management of irAEs of immune checkpoint blockers:
- Infliximab and Methotrexate: no impact on survival
- Steroids alone: worse outcome
- Better early use of immunosuppressants?”
Read further.
Source: Arndt Vogel/X
About OncoDaily
OncoDailyΒ was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is βCancer doesnβt take a day off β neither do we.β
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023